MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
SRRK reached the all-time high after the close of the market on Tuesday as the stock skyrocketed on positive SRK-015 results.
Scholar Rock Holding Corporation...
MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
SRRK reached the all-time high after the close of the market on Tuesday as the stock skyrocketed on positive SRK-015 results.
Scholar Rock Holding Corporation...
MGI records money transfer revenue growth of 5% led by 10% YoY growth while MGO cross-border transaction sees 176% YoY growth.
Shares of MoneyGram International,...
BLRX trades on heavy volume after compelling Phase 3 Trials of Motixafortide (BL-8040) for the cancer treatment.
BioLineRx Ltd. (BLRX), a clinical-stage biopharmaceutical firm announced today that...
